Sobi vidareutvecklar Gamifant® (emapalumab) vid gammainterferon-driven sepsis (IDS) baserat på topline-data från EMBRACE (2) ...

Sobi (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant (emapalumab) for interferon-gamma (IFN?)-driven ...

The Maternal Care Bundle (MCB) sets best practice standards across 5 areas of clinical care, for implementation by NHS providers and commissioners across England. The aim is to reduce maternal ...

InduPro, Inc., a biotechnology company defining membrane protein spatial relationships to create novel therapeutics for the treatment of cancer and autoimmune diseases, today announced a global ...

Indian drugmakers, known for their chemistry and prowess in making generics—cheaper copies of innovative drugs—for the world, ...

Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...

New AIIMS-ICMR Study Finds Heart Problems Behind Sudden Young Deaths Sudden deaths in seemingly healthy young adults are ...

Background Annually, 4% of the global population undergoes non-cardiac surgery, with 30% of those patients having at least ...

The Ethiopian Neonatal Network (ENN) represents one of the first low-income country neonatal quality improvement (QI) ...

A simple blood test can tell doctors when it is safe to stop antibiotics in patients recovering from sepsis, a review led by ...

Over the course of five years, the researchers studied patients with HIV-related sepsis in eastern Africa, discovering that ...

Early recognition of sepsis remains challenging given heterogeneity in presentation. Existing screening tools have not yet ...